SCHEMBL4763386

SCHEMBL4763386

COC(C)n1c(C=Cc2cnn(Cc3ccccc3C(F)(F)F)c2)c([N+](=O)[O-])c(=O)n(C(C)OC)c1=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
NPBWR1 P48145 1/20 0.37
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
MAPK1 P28482 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
POLB P06746 1/20 0.34
TAS2R8 Q9NYW2 1/20 0.34
SCD5 Q86SK9 1/20 0.33
NCOA1 Q15788 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.32
MITF O75030 1/20 0.32
LMNA P02545 1/20 0.31
P2RX7 Q99572 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763383 1.00 ADORA2A (0.38) ADORA2AADORA2BADORA1NPBWR1ALDH1A1
SCHEMBL4766146 0.92 ADORA2B (0.45) ADORA2AADORA2BADORA1NPBWR1ALDH1A1
SCHEMBL4766136 0.92 ADORA2B (0.45) ADORA2AADORA2BADORA1NPBWR1ALDH1A1
SCHEMBL4769323 0.89 ADORA2B (0.42) ADORA2AADORA2BADORA1NPBWR1ALDH1A1
SCHEMBL4771422 0.89 MAPT (0.38) ADORA2AADORA2BADORA1ALDH1A1MAPT
SCHEMBL4771433 0.89 MAPT (0.38) ADORA2AADORA2BADORA1ALDH1A1MAPT
SCHEMBL4763163 0.89 ADORA2A (0.37) ADORA2AADORA2BADORA1NPBWR1ALDH1A1
SCHEMBL4763169 0.89 ADORA2A (0.37) ADORA2AADORA2BADORA1NPBWR1ALDH1A1
SCHEMBL4765672 0.86 ADORA2A (0.36) ADORA2AADORA2BADORA1NPBWR1ALDH1A1
SCHEMBL4765675 0.86 ADORA2A (0.36) ADORA2AADORA2BADORA1NPBWR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed